Large-scale testing (Phase 3)WithdrawnNCT00243568
What this trial is testing
Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285
Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC